{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:15:51Z","timestamp":1726100151400},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"Abstract<\/jats:title>Background<\/jats:title>Acute myeloid leukemia (AML) is a heterogeneous cancer of the blood, though specific recurring cytogenetic abnormalities in AML are strongly associated with attaining complete response after induction chemotherapy, remission duration, and survival. Therefore recurring cytogenetic abnormalities have been used to segregate patients into favorable, intermediate, and adverse prognostic risk groups. However, it is unclear how expression of genes is associated with these prognostic risk groups. We postulate that expression of genes monotonically associated with these prognostic risk groups may yield important insights into leukemogenesis. Therefore, in this paper we propose penalized Bayesian ordinal response models to predict prognostic risk group using gene expression data. We consider a double exponential prior, a spike-and-slab normal prior, a spike-and-slab double exponential prior, and a regression-based approach with variable inclusion indicators for modeling our high-dimensional ordinal response, prognostic risk group, and identify genes through hypothesis tests using Bayes factor.<\/jats:p><\/jats:sec>Results<\/jats:title>Gene expression was ascertained using Affymetrix HG-U133Plus2.0 GeneChips for 97 favorable, 259 intermediate, and 97 adverse risk AML patients. When applying our penalized Bayesian ordinal response models, genes identified for model inclusion were consistent among the four different models. Additionally, the genes included in the models were biologically plausible, as most have been previously associated with either AML or other types of cancer.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>These findings demonstrate that our proposed penalized Bayesian ordinal response models are useful for performing variable selection for high-dimensional genomic data and have the potential to identify genes relevantly associated with an ordinal phenotype.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12859-021-04432-w","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T16:39:22Z","timestamp":1635871162000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bayesian variable selection for high-dimensional data with an ordinal response: identifying genes associated with prognostic risk group in acute myeloid leukemia"],"prefix":"10.1186","volume":"22","author":[{"given":"Yiran","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Kellie J.","family":"Archer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"issue":"12","key":"4432_CR1","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting\u2014Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835\u201349.","journal-title":"J Clin Oncol"},{"key":"4432_CR2","doi-asserted-by":"crossref","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial the Medical Research Council Adult and Children\u2019s Leukemia working parties. Blood. 1998;92:2322\u201333.","DOI":"10.1182\/blood.V92.7.2322.2322_2322_2333"},{"issue":"13","key":"4432_CR3","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mr\u00f2zek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PRK, Moore JO, Stone RM, Mayer RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100(13):4325\u201336.","journal-title":"Blood"},{"issue":"21","key":"4432_CR4","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1200\/JCO.2004.11.106","volume":"22","author":"JE Kolitz","year":"2004","unstructured":"Kolitz JE, George SL, Dodge RK, Hurd DD, Powell BL, Allen SL, Velez-Garcia E, Moore JO, Shea TC, Hoke E, Caligiuri MA, Vardiman JW, Bloomfield CD, Larson RA. Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: Final induction results of Cancer and Leukemia Group B study 9621. J Clin Oncol. 2004;22(21):4290\u2013301.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4432_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc: Ser B (Methodol). 1996;58(1):267\u201388.","journal-title":"J R Stat Soc: Ser B (Methodol)"},{"key":"4432_CR6","doi-asserted-by":"publisher","first-page":"20806","DOI":"10.4137\/CIN.S20806","volume":"13","author":"KJ Archer","year":"2014","unstructured":"Archer KJ, Hou J, Zhou Q, Ferber K, Layne JG, Gentry AE. ordinalgmifs: an R package for ordinal regression in high-dimensional data settings. Cancer Inf. 2014;13:20806.","journal-title":"Cancer Inf"},{"key":"4432_CR7","unstructured":"Wurm MJ, Rathouz PJ, Hanlon BM. Regularized ordinal regression and the ordinalNet R package, 2017. arXiv preprint arXiv:1706.05003."},{"issue":"13","key":"4432_CR8","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","volume":"113","author":"BJ Wouters","year":"2009","unstructured":"Wouters BJ, L\u00f6wenberg B, Erpelinck-Verschueren CAJ, van Putten WLJ, Valk PJM, Delwel R. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood. 2009;113(13):3088\u201391.","journal-title":"Blood"},{"key":"4432_CR9","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1373\/clinchem.2004.033225","volume":"50","author":"CI Dumur","year":"2004","unstructured":"Dumur CI, Nasim S, Best AM, Archer KJ, Ladd AC, Mas VR, Wilkinson DS, Garrett CT, Ferreira-Gonzalez A. Evaluation of quality-control criteria for microarray gene expression analysis. Clin Chem. 2004;50:1994\u20132002.","journal-title":"Clin Chem"},{"key":"4432_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249\u201364.","journal-title":"Biostatistics"},{"key":"4432_CR11","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1182\/blood-2005-05-2168","volume":"106","author":"RGW Verhaak","year":"2005","unstructured":"Verhaak RGW, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W, Uitterlinden AG, Erpelinck CAJ, Delwel R, L\u00f6wenberg B, Valk PJM. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood. 2005;106:3747\u201354.","journal-title":"Blood"},{"key":"4432_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-4286-2","volume-title":"Statistical decision theory and Bayesian analysis","author":"JO Berger","year":"1985","unstructured":"Berger JO. Statistical decision theory and Bayesian analysis. New York: Springer; 1985."},{"key":"4432_CR13","first-page":"163","volume-title":"Markov chain Monte Carlo in practice","author":"AE Raftery","year":"1996","unstructured":"Raftery AE, et al. Hypothesis testing and model selection via posterior simulation. In: Gilks WR, Spiegelhalter DJ, Richardson S, editors., et al., Markov chain Monte Carlo in practice. Chapman and Hall; 1996. p. 163\u201388."},{"issue":"2","key":"4432_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1541-0420.2011.01680.x","volume":"68","author":"S Biswas","year":"2012","unstructured":"Biswas S, Lin S. Logistic Bayesian LASSO for identifying association with rare haplotypes and application to age-related macular degeneration. Biometrics. 2012;68(2):587\u201397.","journal-title":"Biometrics"},{"issue":"423","key":"4432_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/01621459.1993.10476353","volume":"88","author":"EI George","year":"1993","unstructured":"George EI, McCulloch RE. Variable selection via Gibbs sampling. J Am Stat Assoc. 1993;88(423):881\u20139.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"4432_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11222-009-9158-3","volume":"20","author":"L Fahrmeir","year":"2010","unstructured":"Fahrmeir L, Kneib T, Konrath S. Bayesian regularisation in structured additive regression: a unifying perspective on shrinkage, smoothing and predictor selection. Stat Comput. 2010;20(2):203\u201319.","journal-title":"Stat Comput"},{"issue":"10","key":"4432_CR17","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1093\/bioinformatics\/bti319","volume":"21","author":"KY Yeung","year":"2005","unstructured":"Yeung KY, Bumgarner RE, Raftery AE. Bayesian model averaging: development of an improved multi-class, gene selection and classification tool for microarray data. Bioinformatics. 2005;21(10):2394\u2013401.","journal-title":"Bioinformatics"},{"issue":"430","key":"4432_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","volume":"90","author":"RE Kass","year":"1995","unstructured":"Kass RE, Raftery AE. Bayes factors. J Am Stat Assoc. 1995;90(430):773\u201395.","journal-title":"J Am Stat Assoc"},{"key":"4432_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.csda.2004.01.006","volume":"47","author":"DV Nguyen","year":"2004","unstructured":"Nguyen DV. On estimating the proportion of true null hypotheses for false discovery rate controlling procedures in exploratory DNA microarray studies. Comput Stat Data Anal. 2004;47:611\u201337.","journal-title":"Comput Stat Data Anal"},{"issue":"1","key":"4432_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1534\/genetics.116.192195","volume":"205","author":"Z Tang","year":"2017","unstructured":"Tang Z, Shen Y, Zhang X, Yi N. The spike-and-slab lasso generalized linear models for prediction and associated genes detection. Genetics. 2017;205(1):77\u201388.","journal-title":"Genetics"},{"key":"4432_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12885-018-4483-6","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li B, Han H, Song S, Xu H, Hong Y, Yi N, Zhuang W. Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression. BMC Cancer. 2018;18:551.","journal-title":"BMC Cancer"},{"issue":"9","key":"4432_CR22","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1182\/blood-2006-08-040147","volume":"109","author":"S Agrawal","year":"2007","unstructured":"Agrawal S, Hofmaann W-K, Tidow N, Ehrich M, van den Boom D, Koschmieder S, Berdel WE, Serve H, M\u00fcller-Tidow C. The C\/EBP\u03b4 tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood. 2007;109(9):3895\u2013905.","journal-title":"Blood"},{"issue":"8","key":"4432_CR23","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2012-07-442004","volume":"121","author":"Z Li","year":"2014","unstructured":"Li Z, Zhang Z, Li Y, Arnovitz S, Chen P, Huang H, Jiang X, Hong G-M, Kunjamma RB, Ren H, He C, Wang C-Z, Elkahloun AG, Valk PJM, D\u00f6hner K, Neilly MB, Bullinger L, Delwel R, L\u00f6wenberg B, Liu PP, Morgan R, Rowley JD, Yuan C-S, Chen J. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood. 2014;121(8):1422\u201331.","journal-title":"Blood"},{"issue":"1","key":"4432_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1478-811X-10-19","volume":"10","author":"D Arora","year":"2012","unstructured":"Arora D, K\u00f6the S, van den Eijinden M, van Huijsduijnen RH, Heidel F, Fischer T, Scholl S, T\u00f6lle B, B\u00f6hmer S-A, Lennartsson J, Isken F, M\u00fcller-Tidow C, B\u00f6hmer FD. Expression of protein-tyrosine phosphatases in acute myleloid leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression. Cell Commun Signal. 2012;10(1):19.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"4432_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/10428190500054491","volume":"46","author":"JG Kim","year":"2005","unstructured":"Kim JG, Sohn SK, Kim DH, Baek JH, Lee NY, Suh JS, Chae S-C, Lee KS, Lee KB. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma. 2005;46(6):885\u201391.","journal-title":"Leuk Lymphoma"},{"key":"4432_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cyto.2018.05.025","volume":"111","author":"N El Kramani","year":"2018","unstructured":"El Kramani N, Elsherbiny NM, El-Gayar AM, Ebrahim MA, Al-Gaayyaar MMH. Clinical significance of the TNF-\u03b1 receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemia. Cytokine. 2018;111:523\u20139.","journal-title":"Cytokine"},{"key":"4432_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00277-014-2178-x","volume":"94","author":"L Bolkun","year":"2015","unstructured":"Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Ratajczak-Wrona W, Dzieciol J, Kloczko J. The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. Ann Hematol. 2015;94:35\u201343.","journal-title":"Ann Hematol"},{"issue":"1","key":"4432_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nm1161","volume":"11","author":"A Nebbioso","year":"2005","unstructured":"Nebbioso A, Clarke N, Voltz E, Germain E, Ambrosino C, Bontempo P, Alverez R, Schiavone EM, Ferrara F, Bresciani F, Weisz A, de Lera AR, Gronemeyer H, Altucci L. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat Med. 2005;11(1):77\u201384.","journal-title":"Nat Med"},{"key":"4432_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/febs.14751","volume":"286","author":"G Chen","year":"2019","unstructured":"Chen G, Liu A, Xu Y, Gao L, Jiang M, Li Y, Lv N, Zhou L, Wang L, Yu L, Li Y. The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter. FEBS J. 2019;286:901\u201312.","journal-title":"FEBS J"},{"issue":"6","key":"4432_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/15592294.2015.1048060","volume":"10","author":"X Qu","year":"2015","unstructured":"Qu X, Davison J, Du L, Storer B, Stirewalt DL, Heimfeld S, Estey E, Appelbaum FR, Fang M. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia. Epigenetics. 2015;10(6):526\u201335.","journal-title":"Epigenetics"},{"key":"4432_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2015.10.071","volume":"467","author":"O Lindblad","year":"2015","unstructured":"Lindblad O, Chougule RA, Moharram SA, Kabir NN, Sun J, Kazi JU, R\u00f6nnstrand L. The role of HOXB2 and HOXB3 in acute myeloid leukemia. Biochem Biophys Res Commun. 2015;467:742\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"4432_CR32","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood-2006-05-022988","volume":"108","author":"PB de la Grange","year":"2006","unstructured":"de la Grange PB, Armstrong F, Duval V, Rouyez M-C, Goardon N, Romeo P-H, Pflumio F. Low SCL\/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood. 2006;108(9):2998\u20133004.","journal-title":"Blood"},{"key":"4432_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2019.02.011","volume":"80","author":"M Gasparetto","year":"2019","unstructured":"Gasparetto M, Pei S, Minhajuddin M, Stevens B, Smith CA, Seligman P. Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy. Leuk Res. 2019;80:1\u201310.","journal-title":"Leuk Res"},{"key":"4432_CR34","first-page":"1125","volume":"324","author":"C Perrin","year":"2001","unstructured":"Perrin C, Bayle J, Bannwarth S, Michiels J-F, Heudire P, Lefebvre J-C, Giordanengo V. Expression of LSLCL, a new C-type lectin, is closely restricted, in bone marrow, to immature neutrophils. Life Sci. 2001;324:1125\u201332.","journal-title":"Life Sci"},{"key":"4432_CR35","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1073\/pnas.082099299","volume":"99","author":"R Tibshirani","year":"2002","unstructured":"Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA. 2002;99:6567\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4432_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/bjh.16360","volume":"188","author":"T Haferlach","year":"2020","unstructured":"Haferlach T, Schmidts I. The power and potential of integrated diagnostics in acute myeloid leukaemia. Br J Haematol. 2020;188:36\u201348.","journal-title":"Br J Haematol"},{"issue":"3","key":"4432_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H, Estey E, Amadori S, Appelbaum F, B\u00fcchner T, Burnett A, Dombret H, Fenaux P, Grimwade D, Larson R, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele G, Sanz M, Sierra J, Tallman M, L\u00f6wenberg B, Bloomfield C, LeukemiaNet E. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453\u201374.","journal-title":"Blood"},{"key":"4432_CR38","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1200\/JCO.2012.43.4738","volume":"30","author":"K Mr\u00f2zek","year":"2012","unstructured":"Mr\u00f2zek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ, Kohlschmidt J, Pettenati MJ, Heerema NA, Block AW, Patil SR, Baer MR, Kolitz JE, Moore JO, Carroll AJ, Stone RM, Larson RA, Bloomfield CD. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 2012;30:4515\u201323.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4432_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum F, B\u00fcchner T, Dombret H, Ebert E, Fenaux P, Larson R, Levine R, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele G, Sanz M, Sierra J, Tallman M, HF T, AH W, L\u00f6wenberg B, Bloomfield C. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347.","journal-title":"Blood"},{"issue":"6","key":"4432_CR40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/sim.8851","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Archer KJ. Bayesian penalized cumulative logit model for high-dimensional data with an ordinal response. Stat Med. 2021;40(6):1453\u201381.","journal-title":"Stat Med"},{"key":"4432_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/9780470594001","volume-title":"Analysis of ordinal categorical data","author":"A Agresti","year":"2010","unstructured":"Agresti A. Analysis of ordinal categorical data. Wiley; 2010."},{"key":"4432_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models","author":"P McCullagh","year":"1989","unstructured":"McCullagh P, Nelder JA. Generalized linear models, vol. 37. CRC Press; 1989."},{"issue":"422","key":"4432_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/01621459.1993.10476321","volume":"88","author":"JH Albert","year":"1993","unstructured":"Albert JH, Chib S. Bayesian analysis of binary and polychotomous response data. J Am Stat Assoc. 1993;88(422):669\u201379.","journal-title":"J Am Stat Assoc"},{"key":"4432_CR44","doi-asserted-by":"crossref","unstructured":"Geman S, Geman D. Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images. In: Readings in computer vision. Elsevier; 1987. p. 564\u201384.","DOI":"10.1016\/B978-0-08-051581-6.50057-X"},{"issue":"410","key":"4432_CR45","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/01621459.1990.10476213","volume":"85","author":"AE Gelfand","year":"1990","unstructured":"Gelfand AE, Smith AF. Sampling-based approaches to calculating marginal densities. J Am Stat Assoc. 1990;85(410):398\u2013409.","journal-title":"J Am Stat Assoc"},{"key":"4432_CR46","doi-asserted-by":"crossref","unstructured":"Albert JH. Bayesian ordinal regression modeling. In: Wiley StatsRef: Statistics Reference Online. 2016.","DOI":"10.1002\/9781118445112.stat07867"},{"issue":"482","key":"4432_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1198\/016214508000000337","volume":"103","author":"T Park","year":"2008","unstructured":"Park T, Casella G. The Bayesian lasso. J Am Stat Assoc. 2008;103(482):681\u20136.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"4432_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1534\/genetics.107.085589","volume":"179","author":"N Yi","year":"2008","unstructured":"Yi N, Xu S. Bayesian LASSO for quantitative trait loci mapping. Genetics. 2008;179(2):1045\u201355.","journal-title":"Genetics"},{"issue":"4","key":"4432_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/bioinformatics\/btq688","volume":"27","author":"J Li","year":"2010","unstructured":"Li J, Das K, Fu G, Li R, Wu R. The Bayesian lasso for genome-wide association studies. Bioinformatics. 2010;27(4):516\u201323.","journal-title":"Bioinformatics"},{"issue":"5","key":"4432_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/wics.176","volume":"3","author":"A Lykou","year":"2011","unstructured":"Lykou A, Ntzoufras I. WinBUGS: a tutorial. Wiley Interdiscip Rev Comput Stat. 2011;3(5):385\u201396.","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"issue":"9","key":"4432_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/jhg.2017.43","volume":"62","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Hofmann JN, Purdue MP, Lin S, Biswas S. Logistic Bayesian LASSO for genetic association analysis of data from complex sampling designs. J Hum Genet. 2017;62(9):819.","journal-title":"J Hum Genet"},{"issue":"404","key":"4432_CR52","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/01621459.1988.10478694","volume":"83","author":"TJ Mitchell","year":"1988","unstructured":"Mitchell TJ, Beauchamp JJ. Bayesian variable selection in linear regression. J Am Stat Assoc. 1988;83(404):1023\u201332.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"4432_CR53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1011916902934","volume":"11","author":"R Kohn","year":"2001","unstructured":"Kohn R, Smith M, Chan D. Nonparametric regression using linear combinations of basis functions. Stat Comput. 2001;11(4):313\u201322.","journal-title":"Stat Comput"},{"issue":"472","key":"4432_CR54","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1198\/016214505000000367","volume":"100","author":"M Yuan","year":"2005","unstructured":"Yuan M, Lin Y. Efficient empirical Bayes variable selection and estimation in linear models. J Am Stat Assoc. 2005;100(472):1215\u201325.","journal-title":"J Am Stat Assoc"},{"issue":"521","key":"4432_CR55","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/01621459.2016.1260469","volume":"113","author":"V Ro\u010dkov\u00e1","year":"2018","unstructured":"Ro\u010dkov\u00e1 V, George EI. The spike-and-slab LASSO. J Am Stat Assoc. 2018;113(521):431\u201344.","journal-title":"J Am Stat Assoc"},{"issue":"18","key":"4432_CR56","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/bioinformatics\/btx300","volume":"33","author":"Z Tang","year":"2017","unstructured":"Tang Z, Shen Y, Zhang X, Yi N. The spike-and-slab lasso Cox model for survival prediction and associated genes detection. Bioinformatics. 2017;33(18):2799\u2013807.","journal-title":"Bioinformatics"},{"key":"4432_CR57","first-page":"65","volume":"60","author":"L Kuo","year":"1998","unstructured":"Kuo L, Mallick B. Variable selection for regression models. Sankhy\u0101 Indian J Stat Ser B. 1998;60:65\u201381.","journal-title":"Sankhy\u0101 Indian J Stat Ser B"},{"volume-title":"Bayesian statistics","year":"1996","author":"J Geweke","key":"4432_CR58","unstructured":"Geweke J. Variable selection and model comparison in regression. In: Bernardo JM, Berger JO, Dawid AP, Smith A, editors. Bayesian statistics, vol. 5. Oxford Press; 1996."},{"issue":"1","key":"4432_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1023\/A:1013164120801","volume":"12","author":"P Dellaportas","year":"2002","unstructured":"Dellaportas P, Forster JJ, Ntzoufras I. On Bayesian model and variable selection using MCMC. Stat Comput. 2002;12(1):27\u201336.","journal-title":"Stat Comput"},{"issue":"3","key":"4432_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11222-012-9316-x","volume":"23","author":"A Lykou","year":"2013","unstructured":"Lykou A, Ntzoufras I. On Bayesian lasso variable selection and the specification of the shrinkage parameter. Stat Comput. 2013;23(3):361\u201390.","journal-title":"Stat Comput"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-021-04432-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T09:00:01Z","timestamp":1726045201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-04432-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-04432-w","relation":{},"ISSN":["1471-2105"],"issn-type":[{"type":"electronic","value":"1471-2105"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}